Navigation Links
Abbott's XIENCE V(R) Demonstrates Impressive Low Rates of Repeat Procedure, Stent Thrombosis and Major Adverse Cardiac Events in Complex, 'Real World' Patients in SPIRIT V Study
Date:5/21/2009

p>

Abbott also supplies a private-label version of XIENCE V to Boston Scientific called the PROMUS(R) Everolimus-Eluting Coronary Stent System. PROMUS is designed and manufactured by Abbott and supplied to Boston Scientific as part of a distribution agreement between the two companies.

Everolimus, developed by Novartis Pharma AG, is a proliferation signal inhibitor, or mTOR inhibitor, licensed to Abbott by Novartis for use on its drug eluting stents. Everolimus has been shown to inhibit in-stent neointimal growth in the coronary vessels following stent implantation, due to its antiproliferative properties.

Additional information about XIENCE V, including important safety and effectiveness information, is available online at www.xiencev.com.

About Abbott Vascular

Abbott Vascular, a division of Abbott, is one of the world's leading vascular care businesses. Abbott Vascular is uniquely focused on advancing the treatment of vascular disease and improving patient care by combining the latest medical device innovations with world-class pharmaceuticals, investing in research and development, and advancing medicine through training and education. Headquartered in Northern California, Abbott Vascular offers a comprehensive portfolio of vessel closure, endovascular and coronary products.

About Abbott

Abbott (NYSE: ABT) is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs more than 72,000 people and markets its products in more than 130 countries.

Abbott's news releases and other information are available on the company's Web site a
'/>"/>

SOURCE Abbott
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Abbott Begins U.S. Study of XIENCE V(TM) Drug Eluting Stent Designed for Small Vessels
2. Abbott Submits Application for Approval of XIENCE(TM) V Everolimus Eluting Coronary Stent System in Japan
3. Spirit II explores long-term performance of XIENCE V stent
4. Abbott Receives CE Mark for Smaller-Size XIENCE(TM) V Drug Eluting Stent
5. FDA Advisory Committee Recommends Approval of Abbotts XIENCE(TM) V Drug Eluting Stent System
6. Boston Scientific Welcomes FDA Panel Recommendation to Approve PROMUS(TM) / XIENCE(TM) V Everolimus-eluting Coronary Stent System
7. Ted Karkus Admits to Financial Relationship With Dr. Richard A. Rosenbloom; Demonstrates Pattern of Improper Influence, Unethical Behavior, Falsification and Distortion; Company Questions What Else Karkus May Be Hiding From Shareholders
8. Siemens Demonstrates Groundbreaking Approach to Stroke Diagnosis at ASNR 2009
9. Concord Coalition Says New Trustees Report Demonstrates the Importance of Health Care Cost Control
10. Ben-Gurion U of the Negev study demonstrates link between appetite and elderly mortality
11. New Research Demonstrates that Wild Blueberries May Support Cardiovascular Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... NJ (PRWEB) May 30, 2015 ... ever changing local and federal regulations, we provide ... of their patients who are suffering from pain, ... says Srinivas Nalamachu, MD, professor of rehabilitation medicine ... Institute in Overland Park, Kansas. , A new ...
(Date:5/29/2015)... M3 USA MDLinx.com, source of the ... specialties, now offers The Smartest Rheumatologist . The ... disorders ranging from Fibromyalgia and Osteoporosis, to Arthritis and ... MDLinx, and Caroline Tredway, editorial head of The Smartest ... have on the physicians who participate. Says Tredway, “With ...
(Date:5/29/2015)... The science of Follicular Unit Extraction ... more efficient methods of FUE hair transplantation have increased the ... the most cutting edge hair transplant methods being used to ... of extracting hair from the beard to the scalp. , ... correct male pattern baldness. Beard hair has a life ...
(Date:5/29/2015)... 29, 2015 Jan Wooden Howse lost her ... thing above all else: God does no wrong. , It’s ... her son’s passing is titled “God Does No Wrong.” It ... with great personal tragedy. , “My story has a ... to you into something productive, something healing,” Howse said. , ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 World Patent ... products, announces that it has signed a 10 year ... patent that aims to let people learn about any ... real time. , "This is an exciting day for ... said Scott J. Cooper, CEO and Creative Director of ...
Breaking Medicine News(10 mins):Health News:PAINWeekEnd Kansas City: Pain Management CME for the Main Street Practitioner 2Health News:MDLinx Launches Smartest Rheumatologist 2Health News:Beard to Scalp Hair Transplant: Newest Advance in Hair Transplant Technology 2Health News:Turning grief from a child’s passing into virtue 2Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 2Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 3Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 4Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 5
... technologies, testing methods, and processes to improve medical decontamination efforts. ... in other industries, and is using that knowledge to help improve ... ... Midbrook, Inc., a Jackson, MI based manufacturer of medical decontamination ...
... SAN ANTONIO, May 12 Eye Care Centers of ... acquired $65,360,000 of ECCA,s 10-3/4 percent Senior Subordinated Notes ... managed and/or advised by DDJ Capital Management, LLC were ... amount, plus accrued interest to the purchase date. The ...
... a meeting today with President Obama and business leaders, ... drew praise for their innovative employee health care and ... the meeting, President Obama referred to the participants, which ... President and CEO Steven Burd, as "some of the ...
... today,s release of the annual Social Security and ... two largest programs are on a troubled fiscal ... together on reforms of both programs aimed at ... to recognize the underlying structural factors contributing to ...
... Minn. -- Mayo Clinic and Grameen Healthcare are ... leveraging Mayo Clinic,s knowledge and expertise in health ... models. A multi-disciplinary team from Mayo Clinic has ... where it was agreed that following an initial ...
... FARMINGDALE, N.Y., May 12 Misonix, Inc. (Nasdaq: ... medical device technology, which in Europe is used for ... health conditions, has announced their attendance and participation in ... held in Los Angeles, CA, March 19-21, 2009. ...
Cached Medicine News:Health News:Midbrook Developing Decontamination Standards for Medical Industry 2Health News:Midbrook Developing Decontamination Standards for Medical Industry 3Health News:President Obama Praises Retailers as Part of the Health Care Solution 2Health News:Concord Coalition Says New Trustees' Report Demonstrates the Importance of Health Care Cost Control 2Health News:Mayo Clinic and Grameen Healthcare join forces to launch demonstration project 2Health News:Misonix Announces Participation in Annual Diabetic Foot Global Conference 2Health News:Misonix Announces Participation in Annual Diabetic Foot Global Conference 3
(Date:5/29/2015)... , May 29, 2015 Educating ... of the Association for the Advancement of Wound ... With support from AAWC,s corporate partners, the ... Portal on the AAWC website at ... wound care pathway with links to various CME/CEU ...
(Date:5/28/2015)... May 28, 2015 ... the addition of Jain PharmaBiotech,s new report  ...  to their offering.       (Logo: ... gene silencing involves the use of double ... this material is processed into short 21-23 ...
(Date:5/28/2015)... 2015 The controversy surrounding the use ... myomectomies (procedures to remove uterine fibroids) continues, as ... investigating Johnson & Johnson,s Ethicon, Inc. unit, which ... According to the report published by The Wall ... FBI is trying to determine what the company ...
Breaking Medicine Technology:The Association for the Advancement of Wound Care Educates the Public 2Global RNAi Market Report 2015-2024 - Technologies, Markets and Companies 2Global RNAi Market Report 2015-2024 - Technologies, Markets and Companies 3Power Morcellator Attorneys at Bernstein Liebhard LLP Comment on Report That FBI Is Investigating Ethicon Morcellators 2Power Morcellator Attorneys at Bernstein Liebhard LLP Comment on Report That FBI Is Investigating Ethicon Morcellators 3
Enhanced drug and formulary reference with integrated ID treatment guide and tools. Increase patient safety and satisfaction with our premium drug reference....
... STELLARA™ is HIPAA-compliant wireless technology that ... hospital departments and personnel a reality. ... four tages or levels ... patient care, shorter hospital stays and ...
The Duran Flexible Annuloplasty System encompasses both performance and practicality....
... Eppendorf Reference Series 2000 Pipette is a ... a compact and robust design, and superior ... used to operate the measuring stroke and ... Product features:Eppendorf "pipette/tip" system ensures utmost accuracy ...
Medicine Products: